Is OPTIMIZERx Corp (OPRX) overvalued? · rev $92.1M
OPTIMIZERx Corp (OPRX) is a health information services company listed on US.
This page asks whether OPTIMIZERx Corp (OPRX) looks expensive on cached numbers — not a short thesis.
Latest reported OPRX revenue for 2024-12-31 was $92.1M. Net income was -$20.1M. Revenue was up 28.8% from 2023-12-31 to 2024-12-31. OPRX currently screens at market cap $234.9M.
OPRX currently screens at market cap $234.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OPRX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OPRX stock page for the full model, not this heading.
Not investment advice.